BYSI Stock Analysis: Buy, Sell, or Hold?

BYSI - BeyondSpring Inc. Ordinary Shares

PHARMACEUTICAL PREPARATIONS
$1.75
-0.04 (-2.23%) ▼
5d: +8.7%
30d: +4.17%
90d: +8.02%
HOLD
MODERATE Confidence
Analysis Updated: Jun 30, 2026 12:00 AM ET
Earnings: Aug 12, 2026

Get Alerted When BYSI Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
📊 HOLD: BYSI shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
See Forward Earnings Fair Value & Price Prediction →

In-depth Analysis How we analyze

Valuation Analysis: BYSI is currently trading at $1.75, which is considered extended relative to its 30-day fair value range of $1.61 to $1.73.

Technical Outlook: Technically, BYSI is in a uptrend. The price is approaching resistance at $1.80. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.

Market Sentiment: BYSI has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. However, the stock is trading significantly above the average Wall Street target of $1.25. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.

Quick Decision Summary

Current Position EXTENDED
Historical Trading Range $1.61 - $1.73
Company Quality Score 59/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 52.6%

All Signals

  • BEARISH: Price extended above range
  • BULLISH: Strong technical setup (75/100)
  • BULLISH: High volume confirmation
  • BEARISH: Trading 28.6% above Wall St target ($1.25)

Trading Range Analysis

30-Day Trading Range $1.61 - $1.73
Current vs Trading Range EXTENDED

Support & Resistance Levels

Support Level $1.54
Resistance Level $1.80
Current Trend Uptrend
Technical data as of Jun 30, 2026

Fundamental Context

Forward P/E (Next Year Est.) 10.54
Wall Street Target $1.25 (-28.6%)
Revenue Growth (YoY) 14.3%
Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit
bloggers & journalists: you are free to use our charts with attribution.
Last updated: July 01, 2026 1:31 AM ET
Data refreshes hourly during market hours. Next update: 2:31 AM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Technical Signals Check
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for BYSI.

Create Free Account

Already have an account? Log In

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
ONC
BeiGene, Ltd.
STRONG BUY
24 analysts
$412 54 HOLD
INSM
Insmed Inc
STRONG BUY
21 analysts
$197 56 HOLD
BNTX
BioNTech SE
STRONG BUY
21 analysts
$122 54 HOLD
VRDN
Viridian Therapeutics Inc
STRONG BUY
16 analysts
$34 66 BUY
APLS
Apellis Pharmaceuticals …
BUY
22 analysts
$41 59 HOLD

More Analysis for BYSI

BYSI Technical Chart BYSI Price Prediction BYSI Earnings Date BYSI Investment Advisor BYSI Fair Price Analyzer BYSI Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals